BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24019546)

  • 1. Long-term outcomes after pelvic radiation for early-stage endometrial cancer.
    Onsrud M; Cvancarova M; Hellebust TP; Tropé CG; Kristensen GB; Lindemann K
    J Clin Oncol; 2013 Nov; 31(31):3951-6. PubMed ID: 24019546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
    Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
    Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant brachytherapy removes survival disadvantage of local disease extension in stage IIIC endometrial cancer: a SEER registry analysis.
    Rossi PJ; Jani AB; Horowitz IR; Johnstone PA
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):134-8. PubMed ID: 17855014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
    Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
    Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma--a prospective randomized study.
    Sorbe B; Horvath G; Andersson H; Boman K; Lundgren C; Pettersson B
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1249-55. PubMed ID: 21676554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time without symptoms and toxicity (TWIST) analysis of adjuvant radiation therapy for endometrial cancer.
    Jereczek-Fossa BA; Badzio A; Jassem J
    Radiother Oncol; 2004 Aug; 72(2):175-81. PubMed ID: 15297136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
    Alektiar KM; Venkatraman E; Chi DS; Barakat RR
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial.
    Nout RA; Smit VT; Putter H; Jürgenliemk-Schulz IM; Jobsen JJ; Lutgens LC; van der Steen-Banasik EM; Mens JW; Slot A; Kroese MC; van Bunningen BN; Ansink AC; van Putten WL; Creutzberg CL;
    Lancet; 2010 Mar; 375(9717):816-23. PubMed ID: 20206777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does brachytherapy improve survival in addition to external beam radiation therapy in patients with high risk stage I and II endometrial carcinoma?
    Crosby MA; Tward JD; Szabo A; Lee CM; Gaffney DK
    Am J Clin Oncol; 2010 Aug; 33(4):364-9. PubMed ID: 20689365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stage II adenocarcinoma of the endometrium: adjuvant radiotherapy and recurrence patterns.
    Cozad SC
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):205-12. PubMed ID: 18164851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant Pelvic Radiation Therapy±Vaginal Brachytherapy in Patients With High-risk Stage I or Stage II Uterine Papillary Serous, Clear Cell, and High-grade Endometrioid Carcinoma.
    Nagar H; Yan W; Parashar B; Nori D; Chao KS; Christos P; Gupta D; Holcomb K; Caputo T; Wernicke AG
    Am J Clin Oncol; 2016 Aug; 39(4):335-9. PubMed ID: 27028349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy.
    Nelson G; Randall M; Sutton G; Moore D; Hurteau J; Look K
    Gynecol Oncol; 1999 Nov; 75(2):211-4. PubMed ID: 10525373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of vaginal brachytherapy in the treatment of surgical stage I papillary serous or clear cell endometrial cancer.
    Barney BM; Petersen IA; Mariani A; Dowdy SC; Bakkum-Gamez JN; Haddock MG
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):109-15. PubMed ID: 22543202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
    Secord AA; Havrilesky LJ; O'Malley DM; Bae-Jump V; Fleming ND; Broadwater G; Cohn DE; Gehrig PA
    Gynecol Oncol; 2009 Sep; 114(3):442-7. PubMed ID: 19560193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pelvic control following external beam radiation for surgical stage I endometrial adenocarcinoma.
    Rush S; Gal D; Potters L; Bosworth J; Lovecchio J
    Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):851-4. PubMed ID: 7591893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal brachytherapy alone: an alternative to adjuvant whole pelvis radiation for early stage endometrial cancer.
    Jolly S; Vargas C; Kumar T; Weiner S; Brabbins D; Chen P; Floyd W; Martinez AA
    Gynecol Oncol; 2005 Jun; 97(3):887-92. PubMed ID: 15943991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome and late side effects in endometrial cancer patients treated with surgery and postoperative radiation therapy.
    Herrera FG; Cruz OS; Achtari C; Bourhis J; Ozsahin M
    Ann Surg Oncol; 2014 Jul; 21(7):2390-7. PubMed ID: 24604587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nomograms for prediction of outcome with or without adjuvant radiation therapy for patients with endometrial cancer: a pooled analysis of PORTEC-1 and PORTEC-2 trials.
    Creutzberg CL; van Stiphout RG; Nout RA; Lutgens LC; Jürgenliemk-Schulz IM; Jobsen JJ; Smit VT; Lambin P
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):530-9. PubMed ID: 25680597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
    Benedetti Panici P; Basile S; Maneschi F; Alberto Lissoni A; Signorelli M; Scambia G; Angioli R; Tateo S; Mangili G; Katsaros D; Garozzo G; Campagnutta E; Donadello N; Greggi S; Melpignano M; Raspagliesi F; Ragni N; Cormio G; Grassi R; Franchi M; Giannarelli D; Fossati R; Torri V; Amoroso M; Crocè C; Mangioni C
    J Natl Cancer Inst; 2008 Dec; 100(23):1707-16. PubMed ID: 19033573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial.
    Nout RA; Putter H; Jürgenliemk-Schulz IM; Jobsen JJ; Lutgens LC; van der Steen-Banasik EM; Mens JW; Slot A; Stenfert Kroese MC; van Bunningen BN; Smit VT; Nijman HW; van den Tol PP; Creutzberg CL
    J Clin Oncol; 2009 Jul; 27(21):3547-56. PubMed ID: 19546404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.